By contrast, Saja et al. investigated the effect of a single 10 mg subcutaneous dose of vitamin K1 in a cohort of patients with liver disease, including 24 with cirrhosis, and reported no significant changes in PT, fibrinogen, factor VII, protein C, or protein S after 72 h. Here, F2 is linked to liver disorder.